LOC100303728 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.398600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.451600E-01
Normal-vs-Stage2
1.954140E-02
Normal-vs-Stage3
1.060640E-01
Normal-vs-Stage4
2.876600E-01
Stage1-vs-Stage2
1.966430E-01
Stage1-vs-Stage3
2.478400E-01
Stage1-vs-Stage4
3.650200E-01
Stage2-vs-Stage3
7.202000E-01
Stage2-vs-Stage4
4.061800E-01
Stage3-vs-Stage4
5.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.856800E-01
Normal-vs-AfricanAmerican
2.470000E-01
Normal-vs-Asian
7.537800E-02
Caucasian-vs-AfricanAmerican
9.407200E-01
Caucasian-vs-Asian
2.465000E-01
AfricanAmerican-vs-Asian
5.105200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.031800E-01
Normal-vs-Female
6.537800E-01
Male-vs-Female
1.638030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.397600E-01
Normal-vs-Age(41-60Yrs)
5.771800E-01
Normal-vs-Age(61-80Yrs)
3.424800E-01
Normal-vs-Age(81-100Yrs)
4.682200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.448000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.971200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.574000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.298600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.619500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.706980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.959800E-03
Normal-vs-Daily Drinker
4.188600E-01
Normal-vs-Weekly Drinker
9.099200E-03
Normal-vs-Occasional Drinker
9.534400E-01
Normal-vs-Social Drinker
9.063000E-01
Non Drinker-vs-Daily Drinker
4.051000E-01
Non Drinker-vs-Weekly Drinker
5.705800E-01
Non Drinker-vs-Occasional Drinker
2.566800E-01
Non Drinker-vs-Social Drinker
1.150650E-01
Daily Drinker-vs-Weekly Drinker
2.781000E-01
Daily Drinker-vs-Occasional Drinker
4.463600E-01
Daily Drinker-vs-Social Drinker
3.106400E-01
Weekly Drinker-vs-Occasional Drinker
2.119800E-01
Weekly Drinker-vs-Social Drinker
8.512000E-02
Occasional Drinker-vs-Social Drinker
9.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.124800E-01
Normal-vs-Grade 2
4.212800E-01
Normal-vs-Grade 3
3.179600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.224300E-02
Grade 1-vs-Grade 3
1.730030E-02
Grade 1-vs-Grade 4
4.124800E-01
Grade 2-vs-Grade 3
6.243800E-01
Grade 2-vs-Grade 4
4.212800E-01
Grade 3-vs-Grade 4
3.179600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.278600E-01
Normal-vs-NonDiabetic
5.760200E-01
Diabetic-vs-NonDiabetic
1.807020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.887210E-01
Normal-vs-NoPancreatitis
5.182000E-01
Pancreatitis-vs-NoPancreatitis
7.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.689200E-01
Normal-vs-N1
2.623600E-02
N0-vs-N1
6.035700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.388100E-02
Normal-vs-TP53-NonMutant
8.761800E-01
TP53-Mutant-vs-TP53-NonMutant
1.800470E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
